Skip to content

Author

Suman Chakrabarty

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Computational strategies for allosteric drug discovery: from cryptic pocket detection to rational design.

Allostery offers a powerful route to regulate protein function and expands drug discovery beyond the orthosteric paradigm. By acting at sites distinct from the active site, allosteric modulators can achieve greater selectivity, reduce off-target effects, and overcome resistance. The discovery of the cryptic switch-II pocket of KRAS, which turned a long-"undruggable" oncoprotein into a clinically validated target, exemplifies this promise. Yet allosteric drug discovery is demanding: it requires not only identifying a suitable, often transient pocket, but also demonstrating that this pocket is functionally coupled to the active site, and then translating that mechanistic insight into design. This perspective surveys the computational strategies addressing each of these challenges in turn: sequence, structure, and machine-learning-based methods for locating allosteric and cryptic sites; network and dynamical analyses for mapping communication pathways; and enhanced-sampling and generative deep-learning approaches for rational modulator design. Throughout, we emphasise a central theme: that generative AI delivers speed and breadth, while physics-based simulation supplies thermodynamic rigour, and that their integration, rather than either alone, defines the most promising path forward. Together with experimental validation, these advances are rapidly expanding our ability to exploit allosteric regulation in therapeutics.

Sutanu Mukhopadhyay, Suman Chakrabarty · 0 citations
Jul 2026

Structural heterogeneity defines the allosteric landscape and conformational selection mechanism of the PDZ2 domain.

The allosteric regulation of PDZ domains is central to cellular signaling, yet whether it is governed primarily by subtle dynamical fluctuations or by structurally distinct conformational states remains unresolved. Here, we address this question for the PDZ2 domain using extensive microsecond-scale molecular dynamics simulations, Markov state models, and complementary state-space clustering analysis. The resulting ensembles reveal substantial conformational heterogeneity in both apo and ligand-bound states, with 14 metastable states identified for the apo ensemble and 9 for the bound ensemble. Quantitative comparison shows that the ligand-bound ensemble occupies a subset of the broader apo conformational landscape, whereas several states are unique to the unbound form, providing strong evidence for conformational selection. Difference contact network and flexibility analyses further show that ligand binding stabilizes the peptide-recognition region while redistributing residue interactions and distal motions across the domain. Together, these findings demonstrate that PDZ2 allostery arises from the coupling between pre-existing structural heterogeneity and ligand-induced network reorganization, providing a mechanistic framework for understanding PDZ regulation and guiding allosteric modulator design.

Sreya Bhowmick, Krishnendu Sinha, Suman Chakrabarty · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.